Hers Review: Program Model, Medication, and Pricing

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where we translate GLP-1 science, weight-management options, and the genetics beneath them into decisions you can actually use. Explore the full Peptides & GLP-1 library.

This is an independent editorial overview. PlexusDx has no affiliate relationship, sponsorship, or commercial tie to Hers or its parent company, Hims & Hers Health.

This page is a straight, single-brand look at Hers rather than a head-to-head. If you are evaluating the Hers weight-loss program on its own terms, here is how it is structured, how it dispenses medication, how to read its pricing, and the genetic dimension it does not address. Market context reflects April 2026.

How the Hers program is built

Hers (Hims & Hers Health) operates as subscription telehealth. In this model you typically complete a virtual clinical evaluation by a licensed provider, receive a written prescription routed to either a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide, and then continue with ongoing follow-up. It is a membership wrapped around clinical access rather than a one-time transaction.

How Hers handles medication

Hers can put you on either a brand-name FDA-approved GLP-1 product or a compounded alternative, depending on your prescription. That single fork drives much of the program's variation: the retail-pharmacy route and the 503A compounding route differ in cost, packaging, and supply. What they share is the compound class, so the medication's core behavior does not hinge on which route Hers uses.

Reading Hers pricing

Published pricing for Hers appears on the brand's own website. Program fees, medication costs, and total monthly spend vary by product (semaglutide vs tirzepatide vs other), subscription tier, and whether the brand dispenses FDA-approved brand products or compounded alternatives. Typical monthly totals in the telehealth GLP-1 market as of April 2026 fall between approximately $200 and $700+, with wide variance. Verify current pricing at Hers's official website before any commitment, because numbers change frequently.

The evidence behind the compounds Hers uses

Hers prescribes from the GLP-1 receptor agonist class: semaglutide, liraglutide, and dulaglutide, plus the GIP/GLP-1 dual agonist tirzepatide, which act on appetite, satiety, and gastric emptying. The trial record belongs to those compounds: STEP for semaglutide (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024). Effect sizes vary with dose, compound, and population.

What the Hers program leaves out

A subscription cannot map your genetics. Variants in GLP1R, the receptor every GLP-1 compound targets, and in FTO, MC4R, and TCF7L2, describe the metabolic terrain the medication acts on. They are pathway-level and do not predict response to any specific compound. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2. Paired with the PlexusDx Weight Management Protocols, which run month to month at $189 for Semaglutide Injection and $289 for Tirzepatide Injection, it supports a test before you invest sequence that a standalone Hers subscription does not include.

No affiliation: PlexusDx has no commercial relationship with Hers and does not represent the company.

More from the Education Hub: What Is GLP 1 and GLP 1 Hormone.

Disclaimer: This overview is educational. PlexusDx is not affiliated with Hers. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Frequently Asked Questions

How does the Hers weight-loss program work?

Hers is subscription telehealth. You complete a virtual evaluation with a licensed provider, receive a prescription routed to either a retail pharmacy for brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide, and continue with follow-up. It is ongoing membership access rather than a single purchase.

Does Hers use brand-name or compounded medication?

It can be either, depending on your prescription. Hers dispenses FDA-approved brand GLP-1 products through a retail pharmacy or compounded semaglutide or tirzepatide through a 503A compounding pharmacy. The route affects cost, packaging, and supply, but the compound class, and therefore the core mechanism, stays the same.

How much does Hers cost?

Hers publishes its own pricing, which varies by product, subscription tier, and dispensing route. Market totals as of April 2026 span roughly $200 to $700 or more, with wide variance. Numbers change often, so verify the current figure on the Hers website before committing rather than relying on a quoted estimate.

Keep learning at the PlexusDx Education Hub. Return to the Peptides & GLP-1 library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.